Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Pitney Bowes, Inc. (PBI)
NYSEIndustrialsIntegrated Freight & LogisticsSnapshot 2026-11-04
$15.65-2.25%
Close 2026-11-05 · 1-day change
NYSEIndustrialsIntegrated Freight & LogisticsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.82 → 1.70 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for PBI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBIT grows to at least $130 million in 2026-Q1 | Operating income is rising, with adjusted EBIT up 9% year over year. | Intact | Adjusted EBIT falls below $120 million in 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a turnaround-style business with elevated risk, not a steady compounder. The thesis is in a watch state: recent signals improved, but weak results, loss-making earnings quality, and volatile management leave progress unproven.
PBI is cheap versus peers, and the evidence describes expectations as broadly justified, with low fragility in current pricing. The valuation gap may reflect the market’s concern about weak recent performance and limited revenue progress; the snapshot does not show that investors expect a full recovery.
Near term, the latest evidence is mixed: adjusted EBIT increased and SendTech costs fell, but consolidated revenue edged lower year over year. Debt reduction and share repurchases show tangible capital-allocation actions, while company-wide revenue stabilization remains behind; the recent earnings beat is positive, but prior deep misses and the sector headwind keep execution risk elevated.
Over the next few quarters, a key test is whether management maintains its recently raised guidance, since a reversal could further weaken credibility. The multi-year view also depends on revenue stabilization and continued cost control, while results and guidance from UPS, FDX, and EXPD could signal whether the broader Industrials backdrop is helping or weakening.
For the next 1 to 3 years, PBI remains a cheap but uncertain recovery story: operating discipline has some support, yet revenue progress and management credibility still need to become more consistent. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Share buybacks are strong, with 17.2 million shares repurchased in 2026-Q1. |
| Intact |
| Share repurchases fall below 15 million shares in 2026-Q1 |
Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 4 supplied quarters. Management reported: “Update on Capital Allocation • Year-to-date through May 1, 2026, the Company repurchased 17.2 million shares for $186 million, including 12.9 million shares for $136 million in the first quarter.” “Update on Capital Allocation Exhibit 99.1 • In Q4, the Company repurchased 12.6 million shares for $127 million.” Delivery assessment Nov 4, 2026 |
Free cash flow of about $362.5 million in FY26 | Pitney Bowes is improving cash flow, with free cash flow at $362.5 million guided for 2026. | Intact | Free cash flow falls below $330 million in FY26 | Free cash flow: $146.081M FY2026-Q3; GAAP. Published target: ~$362.5 million. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 2026146,081,000 USD · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue stabilizes near $1.82 billion in FY26 | A primary condition in Pitney Bowes, Inc.'s published investment case. The stated target is >= $1.8 billion. | Under Pressure | Revenue falls below $1.8 billion in FY26 | Revenue: $456.182M FY2026-Q3; GAAP. Published target: >= $1.8 billion. Annual target cannot be compared with a quarterly or TTM observation. Oct 29, 2026456,182,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.75 → $1.70 · observed estimates
$1.83B → $1.82B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-25 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-26 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-27 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-28 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-29 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-30 | $1.75 | $1,832,748,250 | 6 / 4 |
| 2026-07-31 | $1.79 | $1,836,369,500 | 4 / 3 |
| 2026-08-01 | $1.79 | $1,836,369,500 | 4 / 3 |
| 2026-08-02 | $1.82 | $1,839,624,870 | 6 / 5 |
| 2026-08-03 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-04 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-05 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-06 | $1.82 | $1,836,690,270 | 6 / 5 |
| 2026-08-07 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-08 | $1.82 | $1,836,690,270 | 6 / 5 |
| 2026-08-09 | $1.82 | $1,836,690,270 | 6 / 5 |
| 2026-08-10 | $1.82 | $1,836,690,270 | 6 / 5 |
| 2026-08-12 | $1.82 | $1,836,690,270 | 6 / 5 |
| 2026-08-13 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-14 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-15 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-16 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-17 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-18 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-19 | $1.82 | $1,836,690,267 | 3 / 3 |
| 2026-08-20 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-21 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-22 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-23 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-24 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-25 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-26 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-27 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-28 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-29 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-30 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-08-31 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-01 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-02 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-03 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-04 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-05 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-06 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-07 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-08 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-09 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-10 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-11 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-12 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-13 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-14 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-15 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-16 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-17 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-18 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-19 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-20 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-21 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-22 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-23 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-24 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-25 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-26 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-27 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-28 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-29 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-09-30 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-01 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-02 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-03 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-04 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-05 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-06 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-07 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-08 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-09 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-10 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-11 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-12 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-13 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-14 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-15 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-16 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-17 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-18 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-19 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-20 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-21 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-22 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-23 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-24 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-25 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-26 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-27 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-28 | $1.82 | $1,836,690,267 | 4 / 3 |
| 2026-10-29 | $1.82 | $1,837,470,667 | 4 / 3 |
| 2026-10-30 | $1.79 | $1,831,729,711 | 4 / 3 |
| 2026-10-31 | $1.70 | $1,824,894,911 | 3 / 3 |
| 2026-11-01 | $1.70 | $1,824,894,911 | 3 / 3 |
| 2026-11-02 | $1.70 | $1,824,894,911 | 3 / 3 |
| 2026-11-03 | $1.70 | $1,824,894,911 | 4 / 3 |
| 2026-11-04 | $1.70 | $1,824,894,911 | 4 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.